Global 5-Fluorocytosine (5-FC) market has demonstrated consistent growth, with a valuation reaching US$ 95 million in 2024. Industry projections indicate a steady expansion at a CAGR of 5.1%, expected to elevate the market to approximately US$ 142 million by 2032.